MT-1 vial

MW

1,646.9 g/mol

Purity

>99%

Pigmentation

MT-1

Melanotan I — Alpha-MSH Analog

Synthetic linear analog of alpha-melanocyte-stimulating hormone (α-MSH)

$75

Per vial · Research use only · COA available

Compound Profile

AppearanceLyophilized white powder
Molecular Weight1,646.9 g/mol
Amino Acids13
Dosage10 mg
Volume3 mL
SolubilityBacteriostatic or sterile water
Purity≥98% (HPLC-UV-MS verified)
Storage−20°C long-term · 4°C short-term · Protect from light

Amino Acid Sequence

Ac-Ser-Tyr-Ser-Nle-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2

Third-Party VerifiedCOA AvailableLyophilizedResearch Grade≥98% Purity

COA, sterility, endotoxin, and heavy metal test results available upon request.

For Research Use Only. This product is not for human consumption, clinical use, or veterinary use. Must be 21+ to purchase. Not evaluated or approved by the FDA for any therapeutic use. Introduction into humans or animals is strictly prohibited by law.

Overview

About MT-1

Melanotan I (MT-1), also referred to by its generic name afamelanotide, is a synthetic linear analog of alpha-melanocyte-stimulating hormone. It is studied extensively for its role in melanogenesis — the pathway responsible for melanin production in skin — and for its selective activity at a single melanocortin receptor subtype, which distinguishes it from broader-acting melanocortin agonists.

Mechanism of Action

How It Works

MT-1 is a potent, highly selective agonist at the melanocortin 1 receptor (MC1R), expressed primarily on melanocytes. Receptor activation triggers a cAMP-dependent signaling cascade that upregulates tyrosinase activity and stimulates eumelanin synthesis. Because MT-1 exhibits high MC1R selectivity relative to nonselective melanocortin agonists, research has focused heavily on its pigmentation and photoprotection applications, with comparatively limited activity at MC3R/MC4R — the receptor subtypes linked to appetite and libido effects in other melanocortin peptides.

Scientific Literature

Research Highlights

01

Selective MC1R agonism — targeted melanogenesis with limited off-target receptor activity

02

Tyrosinase upregulation — drives eumelanin synthesis in melanocyte research models

03

Studied for photoprotective potential against UV-induced skin damage

04

Reference compound in erythropoietic protoporphyria photosensitivity research

05

Minimal reported central MC3R/MC4R activity relative to cyclic melanocortin analogs

06

cAMP-mediated signaling cascade studied in melanocyte cell-culture models

07

Long-standing research interest in dermatological and pigmentation science

Research Disclaimer: All research highlights are derived from published preclinical, in vitro, and animal studies. Results observed in laboratory models may not translate to human outcomes. Genfinite makes no claims regarding therapeutic efficacy. All products are sold strictly for scientific research purposes only.

Handling

Storage & Reconstitution

01

Dry Storage

Store lyophilized powder at −20°C, away from light and moisture. Do not open until ready to use. Shelf life is significantly extended by proper dry storage.

02

Reconstitution

Reconstitute using Bacteriostatic or sterile water. Add solvent slowly to the side of the vial and allow to dissolve gently. Do not shake vigorously.

03

Post-Reconstitution

Store reconstituted solution refrigerated at 4°C. Use within your laboratory's established timeframe. Do not refreeze after reconstitution.